Evidence map›Paper›PMID 33665196›Full record

ArticleFrontiers in medicine2021

Clinical Determinants Differentiating the Severity of SARS-CoV-2 Infection in Cancer Patients: Hospital Care or Home Recovery.

Dong D Lin, Yunhong Wu, Sudhamshi Toom, Niki Sheth, Kevin Becker, Susan Burdette-Radoux, James D'Silva, Yiwu Huang, Jay Lipshitz, Trishala Meghal and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Dong D LinDepartment of Volunteers and Student Services, Maimonides Medical Center, Brooklyn, NY, United States.
Yunhong WuDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
Sudhamshi ToomDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Niki ShethDepartment of Radiation Oncology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.
Kevin BeckerDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Susan Burdette-RadouxDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
James D'SilvaDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Yiwu HuangDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Jay LipshitzDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Trishala MeghalDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Lan MoDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Pooja MurthyDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Philip RubinDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Vijaya NatarajanDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Bernadine DonahueDepartment of Radiation Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Yiqing XuDepartment of Medicine, Division of Hematology/Oncology, Maimonides Medical Center, Brooklyn, NY, United States.
Maimonides Medical Center · USHarvard University · USJames J. Peters VA Medical Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asymptomaticcancerchemotherapyCOVID-19immunosuppressiontreatment of negative impact

Identifiers

PMID33665196
PMCPMC7921307
OpenAlexW3130014962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.